Clinical Trials Logo

Pemphigoid clinical trials

View clinical trials related to Pemphigoid.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04555681 Completed - Pemphigoid Clinical Trials

Study of the Periodontal Microbiota in Gingival Cicatricial Pemphigoid Patients. Bicentric Pilot Study.

Start date: January 19, 2021
Phase:
Study type: Observational

In patients with gingival cicatricial pemphigoid (CP), clinical experience has shown that periodontal treatment is beneficial in addition to medical treatment, because the latter does not always allow optimal gingival healing. However in practice, the basic periodontal treatment, combining subgingival scaling and debridement, may be insufficient especially for severe forms of erosive gingivitis. Therefore, a better knowledge of the periopathogenic flora in such patients would facilitate the implementation of a more appropriate and efficient periodontal therapy. In order to meet this objective, we propose a qualitative analysis of the periodontal microbiota in case of gingival CP via a bi-centric observational microbiological pilot study.

NCT ID: NCT03099538 Completed - Bullous Pemphigoid Clinical Trials

Ixekizumab in the Treatment of Bullous Pemphigoid

Start date: August 15, 2017
Phase: Phase 2
Study type: Interventional

Recently, Interleukin (IL)-17 has been identified as a key driver of chronic inflammation in Bullous Pemphigoid (BP). Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this study is to determine the effect of Ixekizumab on BP patients.

NCT ID: NCT02823067 Completed - Pruritus Clinical Trials

Pruritus and Pemphigoid in Nursing Home Patients

SSENIOR
Start date: June 1, 2016
Phase:
Study type: Observational

The primary objective of this observational study is to describe the prevalence of pruritus and pemphigoid in nursing home patients. Secondary outcomes are the relationships of demographic factors and medical risk factors with pemphigoid, including dementia and neuropsychiatric symptoms, medication use and Karnofsky score.